NZ606977A - Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition - Google Patents
Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or conditionInfo
- Publication number
- NZ606977A NZ606977A NZ606977A NZ60697711A NZ606977A NZ 606977 A NZ606977 A NZ 606977A NZ 606977 A NZ606977 A NZ 606977A NZ 60697711 A NZ60697711 A NZ 60697711A NZ 606977 A NZ606977 A NZ 606977A
- Authority
- NZ
- New Zealand
- Prior art keywords
- antibody
- activated
- pharmaceutical composition
- homeopathic
- potentiated form
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 230000001632 homeopathic effect Effects 0.000 abstract 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 4
- 101800004538 Bradykinin Proteins 0.000 abstract 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 2
- 102100035792 Kininogen-1 Human genes 0.000 abstract 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 2
- 229960001340 histamine Drugs 0.000 abstract 2
- 229960005181 morphine Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130352/15A RU2528093C2 (ru) | 2010-07-21 | 2010-07-21 | Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля |
| RU2011125992/15A RU2529783C2 (ru) | 2011-06-24 | 2011-06-24 | Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля |
| PCT/IB2011/002346 WO2012010973A2 (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ606977A true NZ606977A (en) | 2015-08-28 |
Family
ID=44899162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ606977A NZ606977A (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8795657B2 (OSRAM) |
| EP (1) | EP2595655A2 (OSRAM) |
| JP (2) | JP2013533269A (OSRAM) |
| CN (1) | CN103200964A (OSRAM) |
| AR (1) | AR082313A1 (OSRAM) |
| AU (1) | AU2011281247B2 (OSRAM) |
| BR (1) | BR112013001297A2 (OSRAM) |
| CA (1) | CA2805978C (OSRAM) |
| CL (1) | CL2013000202A1 (OSRAM) |
| DE (1) | DE112011102412T5 (OSRAM) |
| EA (1) | EA029228B1 (OSRAM) |
| ES (1) | ES2425315R1 (OSRAM) |
| FR (1) | FR2962909A1 (OSRAM) |
| GB (1) | GB2496800B (OSRAM) |
| IT (1) | ITTO20110638A1 (OSRAM) |
| MX (1) | MX356678B (OSRAM) |
| MY (1) | MY158522A (OSRAM) |
| NZ (1) | NZ606977A (OSRAM) |
| PE (1) | PE20130387A1 (OSRAM) |
| PH (1) | PH12013500142A1 (OSRAM) |
| SG (1) | SG187579A1 (OSRAM) |
| WO (1) | WO2012010973A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| JP2013532182A (ja) | 2010-07-15 | 2013-08-15 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法 |
| EA030566B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция |
| KR20180127515A (ko) * | 2010-07-21 | 2018-11-28 | 올레그 일리치 엡쉬테인 | 당뇨병 및 대사성 장애의 치료를 위한 제약학적 복합 조성물 및 방법들 |
| JP2013533269A (ja) * | 2010-07-21 | 2013-08-22 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び呼吸器の疾患又は状態に関連する疾患及び状態を治療する方法 |
| EP2596019A2 (en) | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| PE20131065A1 (es) * | 2010-07-21 | 2013-09-23 | Oleg Iliich Epshtein | Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular |
| US20130045237A1 (en) * | 2010-08-06 | 2013-02-21 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| DE102020007979A1 (de) | 2020-12-29 | 2022-06-30 | Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie | Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| AU5152293A (en) | 1992-10-08 | 1994-05-09 | Kennedy Institute Of Rheumatology, The | Treatment of autoimmune and inflammatory disorders |
| IT1261849B (it) | 1993-09-02 | 1996-06-03 | Avantgarde Spa | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. |
| US5629286A (en) | 1994-03-31 | 1997-05-13 | Brewitt; Barbara | Homeopathic dilutions of growth factors |
| IL110035A0 (en) | 1994-06-16 | 1994-10-07 | Tapuach Natural Technologies 1 | Homeopathic formulations |
| IL125743A (en) | 1996-02-12 | 2003-09-17 | Epshtein Oleg Iliich | Medicinal preparation containing an active medical substance with homeopathic potentiation |
| US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
| RU2114646C1 (ru) | 1996-09-30 | 1998-07-10 | Олег Ильич Эпштейн | Способ повышения защитных свойств организма при воздействии внешних физических факторов |
| RU2103999C1 (ru) | 1997-01-31 | 1998-02-10 | Олег Ильич Эпштейн | Способ лечения алкоголизма |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2199244C2 (ru) * | 2000-10-05 | 2003-02-27 | Самофалова Лариса Александровна | Способ получения пищевой муки масличных семян |
| RU2197266C1 (ru) | 2001-06-01 | 2003-01-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта |
| RU2191602C1 (ru) | 2001-06-01 | 2002-10-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций |
| RU2199344C1 (ru) * | 2001-12-07 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения синдрома кашля |
| RU2206338C1 (ru) | 2001-12-07 | 2003-06-20 | Эпштейн Олег Ильич | Способ лечения синдрома кашля |
| RU2199345C1 (ru) | 2001-12-26 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции углеводного и жирового обмена |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| RU2209083C1 (ru) | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения кашля |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| WO2004082597A2 (en) | 2003-03-14 | 2004-09-30 | Nutrition Research, Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
| RU2253478C1 (ru) | 2003-10-01 | 2005-06-10 | Эпштейн Олег Ильич | Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества |
| MX2008015621A (es) * | 2006-06-06 | 2009-03-06 | Oleg Iliich Epshtein | Agente medicinal para el tratamiento de obesidad, diabetes y enfermedades relacionadas con la tolerancia deteriorada de glucosa. |
| SG190594A1 (en) * | 2008-04-29 | 2013-06-28 | Gunvant Devichand Oswal | A homeopathic formulation |
| BR112013000842A2 (pt) | 2010-07-15 | 2016-06-07 | Oleg Lliich Epshtein | composições farmacêuticas, método de tratamento de condição de etiologia funcional do trato gastrointestinal e uso de forma potenciada ativada de anticorpo para a proteína s-100, de forma potenciada ativada de anticorpo para histamina e de forma potenciada ativada de anticorpo para a tnf-alfa. |
| NZ606775A (en) | 2010-07-15 | 2015-08-28 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| JP2013532182A (ja) * | 2010-07-15 | 2013-08-15 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法 |
| SG187037A1 (en) * | 2010-07-15 | 2013-02-28 | Oleg Iliich Epshtein | Pharmaceutical compositions and methods of treatment |
| JP2013533269A (ja) * | 2010-07-21 | 2013-08-22 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び呼吸器の疾患又は状態に関連する疾患及び状態を治療する方法 |
| KR20180127515A (ko) * | 2010-07-21 | 2018-11-28 | 올레그 일리치 엡쉬테인 | 당뇨병 및 대사성 장애의 치료를 위한 제약학적 복합 조성물 및 방법들 |
| PE20131065A1 (es) * | 2010-07-21 | 2013-09-23 | Oleg Iliich Epshtein | Composiciones farmaceuticas combinadas y metodo de tratamiento del vertigo, la cinetosis y la distonia vegetativa-vascular |
| US20130045237A1 (en) | 2010-08-06 | 2013-02-21 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
-
2011
- 2011-07-15 JP JP2013520239A patent/JP2013533269A/ja active Pending
- 2011-07-15 GB GB1302926.9A patent/GB2496800B/en not_active Expired - Fee Related
- 2011-07-15 DE DE112011102412T patent/DE112011102412T5/de not_active Withdrawn
- 2011-07-15 FR FR1156475A patent/FR2962909A1/fr not_active Withdrawn
- 2011-07-15 WO PCT/IB2011/002346 patent/WO2012010973A2/en not_active Ceased
- 2011-07-15 ES ES201390008A patent/ES2425315R1/es active Pending
- 2011-07-15 PE PE2013000107A patent/PE20130387A1/es not_active Application Discontinuation
- 2011-07-15 MY MYPI2013000232A patent/MY158522A/en unknown
- 2011-07-15 MX MX2013000806A patent/MX356678B/es active IP Right Grant
- 2011-07-15 EP EP11778681.4A patent/EP2595655A2/en not_active Ceased
- 2011-07-15 PH PH1/2013/500142A patent/PH12013500142A1/en unknown
- 2011-07-15 NZ NZ606977A patent/NZ606977A/en not_active IP Right Cessation
- 2011-07-15 BR BR112013001297A patent/BR112013001297A2/pt not_active Application Discontinuation
- 2011-07-15 SG SG2013004825A patent/SG187579A1/en unknown
- 2011-07-15 CN CN2011800455711A patent/CN103200964A/zh active Pending
- 2011-07-15 IT IT000638A patent/ITTO20110638A1/it unknown
- 2011-07-15 EA EA201300131A patent/EA029228B1/ru not_active IP Right Cessation
- 2011-07-15 US US13/135,884 patent/US8795657B2/en active Active
- 2011-07-15 AU AU2011281247A patent/AU2011281247B2/en not_active Ceased
- 2011-07-15 CA CA2805978A patent/CA2805978C/en not_active Expired - Fee Related
- 2011-07-21 AR ARP110102643A patent/AR082313A1/es unknown
-
2013
- 2013-01-21 CL CL2013000202A patent/CL2013000202A1/es unknown
-
2014
- 2014-07-11 US US14/328,792 patent/US20150023985A1/en not_active Abandoned
-
2016
- 2016-07-01 JP JP2016131753A patent/JP2016216479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG187579A1 (en) | 2013-03-28 |
| BR112013001297A2 (pt) | 2017-11-21 |
| ITTO20110638A1 (it) | 2012-01-22 |
| MX356678B (es) | 2018-06-08 |
| CN103200964A (zh) | 2013-07-10 |
| ES2425315R1 (es) | 2014-09-08 |
| AU2011281247B2 (en) | 2015-07-30 |
| PH12013500142A1 (en) | 2013-03-11 |
| MY158522A (en) | 2016-10-14 |
| JP2013533269A (ja) | 2013-08-22 |
| GB2496800B (en) | 2018-05-23 |
| GB2496800A (en) | 2013-05-22 |
| ES2425315A2 (es) | 2013-10-14 |
| MX2013000806A (es) | 2013-10-28 |
| WO2012010973A3 (en) | 2012-04-26 |
| GB201302926D0 (en) | 2013-04-03 |
| DE112011102412T5 (de) | 2013-07-04 |
| FR2962909A1 (fr) | 2012-01-27 |
| US20120225074A1 (en) | 2012-09-06 |
| US20150023985A1 (en) | 2015-01-22 |
| PE20130387A1 (es) | 2013-03-30 |
| AR082313A1 (es) | 2012-11-28 |
| AU2011281247A1 (en) | 2013-03-14 |
| EP2595655A2 (en) | 2013-05-29 |
| CL2013000202A1 (es) | 2015-01-16 |
| US8795657B2 (en) | 2014-08-05 |
| JP2016216479A (ja) | 2016-12-22 |
| EA029228B1 (ru) | 2018-02-28 |
| WO2012010973A2 (en) | 2012-01-26 |
| EA201300131A1 (ru) | 2013-11-29 |
| CA2805978C (en) | 2016-06-28 |
| CA2805978A1 (en) | 2012-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ606977A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BR112012001297A2 (pt) | conector. | |
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| NZ626954A (en) | Combination therapy of antibodies against human csf-1r and uses thereof | |
| WO2011088120A8 (en) | Antibody formulation and therapeutic regimens | |
| MX2011007589A (es) | Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20. | |
| IN2014CN02448A (OSRAM) | ||
| NZ720736A (en) | Antibody drug conjugates (adcs) with kinesin spindel protein (ksp) | |
| MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
| NZ606964A (en) | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders | |
| PH12014500551A1 (en) | Pharmaceutical composition for inhalation | |
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| JP2013533269A5 (OSRAM) | ||
| HK1225972A1 (zh) | 利用拉喹莫德来延缓亨廷顿氏病的进展 | |
| MX2015016418A (es) | Dihidroetorfina para proporcionar el alivio del dolor y la anestesia. | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| WO2011060253A3 (en) | Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms | |
| HK1187527A1 (en) | N-carboxyalkyl auristatins and the use thereof | |
| NZ777266A (en) | Treatment of circadian rhythm disorders | |
| UA83971U (ru) | Способ лечения гипертонической болезни | |
| RU2010124455A (ru) | Способ лечения пострадавших с сочетанной черепно-мозговой травмой |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 JUL 2018 BY FREEHILLS PATENT ATTORNEYS Effective date: 20160217 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUL 2019 BY FPA PATENT ATTORNEYS PTY LTD Effective date: 20180704 |
|
| LAPS | Patent lapsed |